ANTI PD-L1 ANTIBODY AND USE THEREOF
Provided in the present invention is a PD-L1 immunosuppressant, and specifically provided are a monoclonal antibody capable of targeting PD-L1, and nucleotides, combinations of polynucleotides, expression vectors and combinations of expression vectors encoding the antibody. Also provided in the pres...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
14.12.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided in the present invention is a PD-L1 immunosuppressant, and specifically provided are a monoclonal antibody capable of targeting PD-L1, and nucleotides, combinations of polynucleotides, expression vectors and combinations of expression vectors encoding the antibody. Also provided in the present invention is a conjugate or pharmaceutical composition containing the above-mentioned anti PD-L1 antibody. Further provided in the present invention is the use of the above-mentioned anti PD-L1 antibody, nucleotides, combinations of polynucleotides, expression vectors, combinations of expression vectors, conjugate or pharmaceutical composition in the preparation of a medicament for treating or preventing cancers.
本发明提供了一种PD-L1免疫抑制剂,具体提供了一种能够靶向PD-L1的单克隆抗体以及编码这些抗体的核苷酸、多核苷酸组合、表达载体以及表达载体组合。本发明还提供了包含上述抗PD-L1抗体的偶联物或者药物组合物。本发明还提供了上述抗PD-L1抗体核苷酸、多核苷酸组合、表达载体、表达载体组合、偶联物或者药物组合物在治疗或预防癌症的药物中的用途。 |
---|---|
Bibliography: | Application Number: CN202080013686 |